DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on the company at the following upcoming investor conferences: Links to the webcast will be available on the Dexcom ...

Type 2 diabetes (T2DM) management is complex. With over 42 factors affecting glucose levels, 1 many patients struggle to take ...

DexCom, Inc. (DXCM), headquartered in San Diego, California, is a global leader in the development and manufacturing of ...

ARLINGTON, VA / ACCESS Newswire / August 13, 2025 / FriskaAi announced today an agreement with DexCom, Inc., the global leader in glucose biosensing, to integrate data from Dexcom G7 and Dexcom G6 ...

/ August 13, 2025 / FriskaAi announced today an agreement with DexCom, Inc., the global leader in glucose biosensing, to integrate data from Dexcom G7 and Dexcom G6 Continuous Glucose Monitoring ...